Discover how exosomal MEF2C drives colorectal cancer progression by regulating CD36 transcription, opening new frontiers for early detection and treatment.
Explore how translational research is revolutionizing colorectal cancer treatment through biomarker discovery, proteomics, and personalized medicine approaches.
Exploring the potential of silver nanoparticles in colorectal cancer theranostics - combining diagnosis and therapy in a single platform.
Discover how Malformin A1, a fungal compound, is showing promising results in fighting colorectal cancer through p38 signaling pathway activation.